New Center to Shine Light on the Dark Genome NEW YORK, NY (January 18, 2023) – The New York Genome Center (NYGC) announced the launch of the MacMillan Center for the Study of the Non-Coding Cancer Genome (MCSNCG) today, a major new initiative in cancer research to study the role and function of the non-coding […]
The New York Genome Center (NYGC) is proud to have collaborated on this multi-institutional study which has identified definitive biological links between African ancestry and an aggressive cancer type called triple-negative breast cancer (TNBC). NYGC ‘s involvement includes senior author Dr. Melissa B. Davis, PhD, Ethnicity and Cancer Scholar for NYGC’s Polyethnic-1000 (P-1000) initiative and […]
NEW YORK, NY (January 13, 2022) — “We offer this preliminary report of our experience to date with P-1000 in the hope that investigators in other regions of the USA and other countries will be encouraged to develop similar programs, to make use of the WGS [whole genome sequencing] data that we will ultimately provide, […]
